CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO

Clinical trial NCT03227328 · COMPLETED

Trial details

NCT number: NCT03227328
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Receptor Positive Breast Cancer Metastatic Breast Cancer Hormone Receptor Negative Breast Cancer

Start date: 2017-08-02
Primary completion: 2022-02-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.